Evidence map›Paper›PMID 42136042›Full record

ArticleActa obstetricia et gynecologica Scandinavica2026

Risks of gynecological and breast cancers in women with endometriosis or adenomyosis: A nationwide cohort study.

Louise Moberg, Xinjun Li, Filip Herbst, Filip Jansåker, Arturas Dobilas, Kristina Sundquist, Christer Borgfeldt

Abstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Louise MobergDepartment of Obstetrics and Gynecology, Skåne University Hospital, Sweden.ORCID https://orcid.org/0000-0002-5120-819X
Xinjun LiCenter for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.ORCID https://orcid.org/0000-0002-5559-4657
Filip HerbstDepartment of Obstetrics and Gynecology, Skåne University Hospital, Sweden.ORCID https://orcid.org/0009-0005-2287-3659
Filip JansåkerCenter for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.ORCID https://orcid.org/0000-0003-0670-9996
Arturas DobilasDepartment of Clinical Science Lund, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0001-6884-2640
Kristina SundquistCenter for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.ORCID https://orcid.org/0000-0001-8031-279X
Christer BorgfeldtDepartment of Obstetrics and Gynecology, Linköping University Hospital and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID https://orcid.org/0000-0003-2267-8325

Funding

ALF-YF
6 · The paper itself

Abstract

introductionEndometriosis has been associated with several risk factors for cancer, and population-based research has shown that women with endometriosis have a higher risk of several types of cancer. The aim of this study was to examine the risks of gynecological and breast cancers among women diagnosed with endometriosis or adenomyosis. MATERIAL AND

methodsA nationwide cohort study was conducted between 1997 and 2018. All women diagnosed with endometriosis or adenomyosis (the first recorded diagnosis during the study period) in Sweden were followed for cancer diagnosis. The reference population was women not diagnosed with endometriosis or adenomyosis during the study period. Data were obtained from the National Patient Register (in patient and out patient specialist care settings), the Swedish Cancer Register, and the Total Population Register. Adjusted standardized incidence ratios with 95% confidence intervals were calculated for cancer. Women with prior gynecological organ removal or mastectomy were not excluded.

resultsA total of 49 133 women were diagnosed with endometriosis or adenomyosis at a mean age of 42.7 years (standard deviation: 9.97 years). Of these, 1784 (3.6%) were diagnosed with gynecological or breast cancer. The overall standardized incidence ratio for gynecological and breast cancer in women with endometriosis or adenomyosis for the whole study period was 1.4 (95% confidence interval, 1.3-1.5) compared to those without. For cancers diagnosed in the same calendar year as endometriosis or adenomyosis (n = 370), the standardized incidence ratios were particularly high for endometrial cancer (standardized incidence ratio 47.0) and ovarian (standardized incidence ratio 39.6) cancer. For cancers diagnosed in subsequent calendar years (n = 1414), the standardized incidence ratios were 0.6 (0.5-0.8) for endometrial cancer, 0.7 (0.5-0.9) for cervical cancer, 1.2 (1.1-1.3) for breast cancer, and 1.9 (1.6-2.2) for epithelial ovarian cancers overall. When looking at ovarian cancer subtypes, the standardized incidence ratios were 1.5 (1.1-2.0), 2.8 (1.7-4.2), and 7.7 (5.4-10.6), for low-grade serous, endometrioid, and ovarian clear cell cancers, respectively.

conclusionsWomen with endometriosis or adenomyosis have a higher subsequent risk of ovarian and breast cancers compared to women without. This may represent important information for clinicians and a foundation for further studies on prophylactic interventions.

Indexed as

AdenomyosisBreast NeoplasmsEndometriosisGenital Neoplasms, FemaleAdultCohort StudiesFemaleHumansIncidenceMiddle AgedRegistriesRisk FactorsSwedenbreast cancercervical cancerendometrial cancerendometriosisovarian cancer

Identifiers

PMID42136042
PMCPMC13356466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.